Clinical Trial Update: Mesenchymal Stromal Cells (MSC´s) in Renal Lupus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating mesenchymal stromal cells for systemic lupus erythematosus and lupus glomerulonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Lupus Erythematosus, Systemic, Lupus Glomerulonephritis | Phase 2 | Status: UNKNOWN